Filing Details

Accession Number:
0001104659-11-064063
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-14 18:31:16
Reporting Period:
2011-11-10
Filing Date:
2011-11-14
Accepted Time:
2011-11-14 18:31:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442372 L Stephen Sabba Dorset Management Corp
485 Underhill Blvd Suite 205
Syosset NY 11791
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-10 1,000 $11.69 11,704 No 4 P Direct
Common Stock Acquisiton 2011-11-14 1,000 $11.50 12,704 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. These securities, as represented in Column 5, reflect shares previously reported in a Form 4 filed June 6, 2011.